.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Urinary tract infections (UTIs) represent a significant health burden globally, particularly in environments where empirical antibiotic therapy is standard practice. A recent five-year surveillance study highlights the worsening trends of antimicrobial resistance in uropathogens. This research identifies Escherichia coli and Klebsiella pneumoniae as the dominant pathogens in clinical settings. Specifically, E. coli accounted for 64% of positive cultures, while K. pneumoniae represented nearly 23% of the isolates.
The study observed concerning resistance levels against several first-line treatments. For instance, resistance to amoxicillin-clavulanic acid reached 88%. Furthermore, resistance to third-generation cephalosporins and fluoroquinolones consistently exceeded 50% in both species. These findings mirror the 2024 report from the Indian Council of Medical Research (ICMR). Notably, Indian data confirms high resistance rates in Gram-negative uropathogens, with Klebsiella showing a steady decline in carbapenem susceptibility. Consequently, clinicians should prioritize culture-guided therapy over empirical choices whenever possible. While amikacin and carbapenems still maintain relatively high efficacy, their use requires strict antimicrobial stewardship to prevent further resistance.
Because resistance patterns vary by region, routine monitoring remains essential for effective patient care. Understanding local antimicrobial resistance in uropathogens allows for better-informed empirical treatment decisions. In addition, strengthening diagnostic capabilities can help reduce the over-reliance on broad-spectrum agents. This proactive approach is vital for improving patient outcomes and preserving the remaining effective antibiotics.
High resistance levels reduce the effectiveness of common oral antibiotics like fluoroquinolones. Therefore, healthcare providers may need to use more potent injectable or reserve drugs to achieve clinical cure.
Escherichia coli and Klebsiella pneumoniae are the primary isolates identified in surveillance. Notably, Klebsiella species often exhibit more extensive multi-drug resistance compared to E. coli.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or establish a doctor-patient relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition or treatment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A 5-year surveillance study reveals high resistance in E. coli and Klebsiella uropathogens, highlighting the urgent need for culture-guided UTI therapy....
4 months ago
A parliamentary panel has urged the FSSAI to finalise front-of-pack nutrition labelling regulations without further delay. The committee stressed that simple, color-coded indicators for sugar and clear warning labels are vital to combat dietary non-communicable diseases and guide informed consumer choices.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
Today
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
Today
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
Today
A parliamentary standing committee has directed FSSAI to expedite front-of-pack nutrition labelling regulations. The panel highlighted that over two years of delay since the 2022 draft notification leaves consumers relying on complex numerical labels, urging simple color-coded sugar indicators and warnings.
Today
